-
EP1311302
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1311302
| EP1311302 - PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 05.05.2006 Database last updated on 19.10.2024 | Most recent event Tooltip | 05.05.2006 | Application deemed to be withdrawn | published on 07.06.2006 [2006/23] | Applicant(s) | For all designated states Bristol-Myers Squibb Pharma Company Chestnut Run Plaza 974 Centre Road Wilmington DE 19805 / US | [N/P] |
| Former [2003/21] | For all designated states Bristol-Myers Squibb Pharma Company Chestnut Run Plaza, 974 Centre Road Wilmington, Delaware 19805 / US | Inventor(s) | 01 /
RAJOPADHYE, Milind 21 Honeysuckle Road Westford, MA 01886 / US | 02 /
EDWARDS, D. Scott 123 Farms Drive Burlington, MA 01803 / US | 03 /
BARRETT, John A. 46 Fox Run Groton, MA 01450 / US | 04 /
CARPENTER, Alan P. Jr. 73 Cranberry Hill Lane Carlisle, MA 01741 / US | 05 /
HEMINWAY, Stuart J. 70 High Ledge Avenue Wellesley, MA 02482 / US | 06 /
LIU, Shuang 17 Judith Road Chelmsford, AK 01824 / US | 07 /
SINGH, Prahlad 144 Charlton Street Arlington, MA 02474 / US | [2003/26] |
| Former [2003/21] | 01 /
RAJOPADHYE, Milind 21 Honeysuckle Road Westford, MA 01886 / US | ||
| 02 /
EDWARDS, D., Scott 123 Farms Drive Burlington, MA 01803 / US | |||
| 03 /
BARRETT, John, A. 46 Fox Run Groton, MA 01450 / US | |||
| 04 /
CARPENTER, Alan, P., Jr. 73 Cranberry Hill Lane Carlisle, MA 01741 / US | |||
| 05 /
HEMINWAY, Stuart, J. 71 Rawson Road Arlington, MA 02474 / US | |||
| 06 /
LIU, Shuang 17 Judith Road Chelmsford, AK 01824 / US | |||
| 07 /
SINGH, Prahlad 144 Charlton Street Arlington, MA 02474 / US | Representative(s) | Howard, Paul Nicholas Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2003/21] | Howard, Paul Nicholas Carpmaels & Ransford 43 Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 01946697.8 | 21.06.2001 | [2003/21] | WO2001US20108 | Priority number, date | US20000213206P | 21.06.2000 Original published format: US 213206 P | [2003/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0197860 | Date: | 27.12.2001 | Language: | EN | [2001/52] | Type: | A2 Application without search report | No.: | EP1311302 | Date: | 21.05.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.12.2001 takes the place of the publication of the European patent application. | [2003/21] | Search report(s) | International search report - published on: | EP | 27.02.2003 | Classification | IPC: | A61K51/08, A61K41/00 | [2003/21] | CPC: |
A61K51/088 (EP);
A61K41/0038 (EP);
A61K51/082 (EP);
A61K51/1251 (EP);
A61P19/02 (EP);
A61P29/00 (EP);
A61P35/00 (EP);
A61P41/00 (EP);
A61P43/00 (EP);
A61P9/14 (EP)
(-)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/21] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | PHARMAKA ZUR BILDERZEUGUNG VON ANGIOGENENISCHE ERKRANKUNGEN | [2003/21] | English: | PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS | [2003/21] | French: | PRODUITS PHARMACEUTIQUES POUR L'IMAGERIE DE TROUBLES ANGIOGENIQUES | [2003/21] | Entry into regional phase | 21.01.2003 | National basic fee paid | 21.01.2003 | Designation fee(s) paid | 21.01.2003 | Examination fee paid | Examination procedure | 14.01.2002 | Request for preliminary examination filed International Preliminary Examining Authority: US | 21.01.2003 | Amendment by applicant (claims and/or description) | 21.01.2003 | Examination requested [2003/21] | 22.12.2003 | Despatch of a communication from the examining division (Time limit: M07) | 08.11.2004 | Reply to a communication from the examining division | 04.05.2005 | Despatch of a communication from the examining division (Time limit: M06) | 15.11.2005 | Application deemed to be withdrawn, date of legal effect [2006/23] | 21.12.2005 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2006/23] | Request for further processing for: | 08.11.2004 | Request for further processing filed | 08.11.2004 | Full payment received (date of receipt of payment) Request granted | 07.12.2004 | Decision despatched | Fees paid | Renewal fee | 24.03.2003 | Renewal fee patent year 03 | 14.06.2004 | Renewal fee patent year 04 | 14.06.2005 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO9913329 (BURNHAM INST [US]) [A] 1-11 * page 70, lines 8-15; examples 7,8,11,15; claims 43-48; table 4 *; | [X]WO9958162 (DU PONT PHARM CO [US]) [X] 1-7 * examples 18-21,52,53,57,59; claims 3,6,9,10,13,20-26,40,48,50,51 *; | [E]WO0204030 (DU PONT PHARM CO [US]) [E] 1-11 * page 68; claims 33,46-6173,74,86,88-92 *; | [Y] - DENARDO S J ET AL, "NEOVASCULAR TARGETING WITH CYCLIC RGD PEPTIDE (CRGDF-ACHA) TO ENHANCE DELIVERY OF RADIOIMMUNOTHERAPY", CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, LIEBERT, US, (200002), vol. 15, no. 1, pages 71 - 79, XP000925000 [Y] 1-11 * abstract * | [Y] - WAES1 VAN C ET AL, "EFFECTS OF THE NOVEL ALPHAV INTEGRIN ANTAGONIST SM256 AND CIS-PLATINUM ON GROWTH OF MURINE SQUAMOUS CELL CARCINOMA PAM LY8", INTERNATIONAL JOURNAL OF ONCOLOGY, EDITORIAL ACADEMY OF THE INTERNATIONAL JOURNAL OF ONCOLOGY,, GR, (2000), vol. 16, no. 6, ISSN 1019-6439, pages 1189 - 1195, XP000925238 [Y] 1-11 * see discussion; page 1193, column 2; figure 5 * | [Y] - "CILENGITIDE//ONCOLYTIC ANGIOGENESIS INHIBITOR INTEGRIN ALPHAVBETA3,ALPHAVBETA5 ANTAGONIST", DRUGS OF THE FUTURE, BARCELONA, ES, (2000), vol. 7, no. 25, ISSN 0377-8282, pages 674 - 678, XP008002380 [Y] 1-11 * page 677, column 1 * DOI: http://dx.doi.org/10.1358/dof.2000.025.07.586439 | [T] - LIU S ET AL, "90Y AND 177LU LABELING OF A DOTA-CONJUGATED VITRONECTIN RECEPTOR ANTAGONIST USEFUL FOR TUMOR THERAPY", BIOCONJUGATE CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, (200107), vol. 4, no. 12, ISSN 1043-1802, pages 559 - 568, XP001066363 [T] 1-11 * page 560; figure 1 * DOI: http://dx.doi.org/10.1021/bc000146n | [T] - BURKE P A ET AL, "COMBINED MODALITY RADIOIMMUNOTHERAPY//PROMISE AND PERIL", CANCER, AMERICAN CANCER SOCIETY, PHILADELPHIA, PA, US, (20020215), vol. SUPPL. 4, no. 94, ISSN 0008-543X, pages 1320 - 1331, XP008001988 [T] 1-11 * abstract * DOI: http://dx.doi.org/10.1002/cncr.10303 |